Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 951–1000 of 76231
On July 8, 2026, the Board appointed Kathleen Rubins, Ph.D. as a Class III director of the Board, effective July 8, 2026, to serve until the expiration of her term at the 2029 annual meeting of stockholders.
On July 2, 2026, Mike Schmidt notified Nixxy, Inc. (the "Company") of his decision to resign as Chief Executive Officer of the Company and as a member of the Company's Board of Directors (the "Board"), effective immediately.
On July 2, 2026, the Board appointed David Kratochvil, age 60, who currently serves as a member of the Board, as the Company's Chief Executive Officer.
On July 6, 2026, the Board appointed Ms. Kristina Campbell (“Ms. Campbell”) to serve as a member of the Board, effective immediately.
Mr. Caridi will remain with the Company as Senior Vice President, Business Transformation through his expected retirement on April 30, 2027 and will assist with the transition of his prior responsibilities to Mr. Scognamiglio.
Effective July 9, 2026, John Wiley & Sons, Inc. (the "Company") the Company appointed Frank Scognamiglio as Corporate Vice President, Chief Accounting Officer, to serve as the Company's principal accounting officer, succeeding Christopher Caridi, the Company’s former Chief Accounting Officer.
On July 9, 2026, Enovix Corporation (the “Company”) announced that it is appointing Dr. Michael Vyvoda as Chief Operating Officer of the Company, effective July 29, 2026 (the “Effective Date”).
each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) has indicated their intention to resign as a member of the board of directors of the Company and any committee thereof, as applicable, conditioned upon and effective as of the effective time of the Merger.
each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) has indicated their intention to resign as a member of the board of directors of the Company and any committee thereof, as applicable, conditioned upon and effective as of the effective time of the Merger.
each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) has indicated their intention to resign as a member of the board of directors of the Company and any committee thereof, as applicable, conditioned upon and effective as of the effective time of the Merger.
each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) has indicated their intention to resign as a member of the board of directors of the Company and any committee thereof, as applicable, conditioned upon and effective as of the effective time of the Merger.
each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) has indicated their intention to resign as a member of the board of directors of the Company and any committee thereof, as applicable, conditioned upon and effective as of the effective time of the Merger.
each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) has indicated their intention to resign as a member of the board of directors of the Company and any committee thereof, as applicable, conditioned upon and effective as of the effective time of the Merger.
each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) has indicated their intention to resign as a member of the board of directors of the Company and any committee thereof, as applicable, conditioned upon and effective as of the effective time of the Merger.
Peter Ort resigned as Chief Executive Officer and Co-Chairman
Jeff Tuder resigned as Chief Financial Officer and Co-Chairman
each of Robert Neal, Mark Smith and Eduardo Munemori ceased to be a director of RAAQ
each of Robert Neal, Mark Smith and Eduardo Munemori ceased to be a director of RAAQ
each of Robert Neal, Mark Smith and Eduardo Munemori ceased to be a director of RAAQ
the following individuals also ceased to be directors: Danny H. Salinas, Robert G. Sharp, Louis Zurita and Dr. Mukesh Prasad.
Jane Novak ceased to be Chief Financial Officer
the following individuals also ceased to be directors: Danny H. Salinas, Robert G. Sharp, Louis Zurita and Dr. Mukesh Prasad.
Brandon G. Lutnick ceased to be Chairman and Chief Executive Officer
the following individuals also ceased to be directors: Danny H. Salinas, Robert G. Sharp, Louis Zurita and Dr. Mukesh Prasad.
the following individuals also ceased to be directors: Danny H. Salinas, Robert G. Sharp, Louis Zurita and Dr. Mukesh Prasad.
On July 1, 2026, 374Water Inc. (the “ Company ”) appointed Charles Weiser as Chief Financial Officer (“ CFO ”) of the Company, effective July 1, 2026 (the “ Effective Date ”).
Mr. Richard Soloway, currently Chairman and Chief Executive Officer, will serve as Founder and Executive Chairman
Mr. Kevin Buchel, currently President and Chief Operating Officer, will serve as Chief Executive Officer and President
On July 8, 2026, Ultra Clean Holdings, Inc. (the “Company”) announced that Michael Keogh will become the Company’s next Chief Financial Officer, effective August 5, 2026.
On July 1, 2026, Karen Ferrante, M.D. provided notice to the board of directors (the “Board”) of MacroGenics, Inc. (the “Company”) of her decision to resign from the Board, effective September 1, 2026.
On July 5, 2026, the Board of Directors of Blue Chip Capital Group, Inc. (the “Company”) approved the appointment of Mr. John E. Driscoll as the Company’s Co-Chief Operating Officer.
On July 6, 2026, the Board of Trustees (the “Board”) of Power REIT (the “Trust”) appointed Brent Morrison to serve as an independent trustee of the Trust, effective immediately.
Effective July 3, 2026, Robert Damian Szubanski resigned from his position as the Company's Treasurer, Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer.
Effective July 3, 2026, the Board of Directors elected Radek Chovanec to serve as a Director of the Company.
Concurrently, effective July 3, 2026, Varinia-Rebecca Undine Marie-Anne Koenig resigned from her position as the Secretary of the Company.
Effective July 3, 2026, the Board of Directors appointed Radek Chovanec, age 31, to serve as the Company's Secretary, Treasurer, Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer.
Effective July 7, 2026, John Williams, Jr., a member of the Board of Directors (the “Board”) of Old Second Bancorp, Inc. (the “Company”), resigned from the Board.
Effective July 1, 2026, Mr. Matthew Toboroff was appointed to our Board of Directors to fill a vacancy created by the passing of Thom Kidrin.
On July 3, 2026, the Board of Directors (the “Board”) of Aura Biosciences, Inc. (the “Company”) increased the size of the Board from six to seven directors and unanimously appointed Jeremy Bender, Ph.D., M.B.A., as a Class II director, effective July 7, 2026 (the “Effective Date”), to fill the newly created vacancy.
On July 6, 2026 (the “ Effective Date ”), the Board of Directors (the “ Board ”) of HF Sinclair Corporation (the “ Corporation ”) appointed Steven Ledbetter to the position of President and Chief Operating Officer of the Corporation and Valerie Pompa to the position of President, Growth, Technology and Transformation of the Corporation.
Concurrently with Mr. Ledbetter’s appointment, Mr. Franklin Myers ceased to serve as President and will remain and continue to serve as the Corporation’s Chief Executive Officer.
On July 6, 2026 (the “ Effective Date ”), the Board of Directors (the “ Board ”) of HF Sinclair Corporation (the “ Corporation ”) appointed Steven Ledbetter to the position of President and Chief Operating Officer of the Corporation and Valerie Pompa to the position of President, Growth, Technology and Transformation of the Corporation.
On July 1, 2026, the Board of Directors of Internet Sciences, Inc. (the "Company") appointed Keith R. Wyche to serve as a member of the Board of Directors of the Company, effective July 1, 2026.
On June 30, 2026, Renger van den Heuvel, Crisp Momentum Inc.’s (the “Company”) Chief Executive Officer, principal financial officer, principal accounting officer, and a member of the Company’s Board of Directors (the “Board”), resigned from his officer and director positions with the Company.
appointed the following directors to fill the vacancies created by Mr. van den Heuvel’s resignation and the increase in the size of the Board: Brian McConville Ana Rita Coelho Mariana Mourawad
Also on June 30, 2026, the Company appointed Ana Rita Coelho to serve as Interim Chief Executive Officer, principal financial officer and principal accounting officer.
appointed the following directors to fill the vacancies created by Mr. van den Heuvel’s resignation and the increase in the size of the Board: Brian McConville Ana Rita Coelho Mariana Mourawad
appointed the following directors to fill the vacancies created by Mr. van den Heuvel’s resignation and the increase in the size of the Board: Brian McConville Ana Rita Coelho Mariana Mourawad
Doug Wall 58 Director
Timothy Stebbing 46 Director
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.